{
  "docId": "019dd923-622c-750b-8b99-b43d907adb44",
  "docSlug": "3c210b1fcba7",
  "documentTitle": "Tempus AI, Inc. (TEM)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 9,
  "pageCount": 76,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a red border to emphasize the critical nature of the content.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-b43d907adb44/9",
  "deckHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "This creates the perception of a \"money cycle\".",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-fb91-749f-a6ad-beffd73032df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.96,
        "x": 0.02,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "GlaxoSmithKline: Much like the arrangement with AstraZeneca, our interpretation of the GlaxoSmithKline (GSK) arrangement follows a similar pattern of headline announcements which we believe lack meaningful new financial commitment...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "726be8dc-e5eb-4feb-8308-935ae3520fcb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.96,
        "x": 0.02,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Softbank Joint Venture: There is more evidence of well-timed deals to support the Tempus equity story with aggressive financial engineering and a suspicious joint venture (\"JV\") between Japan's SoftBank and Tempus (\"SB Tempus\")...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d636b0e4-6205-4ef4-94cd-54de765f779e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.96,
        "x": 0.02,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Additional Pathos Concerns: Post-IPO, Lefkofsky, NEA and Director Leonsis and have sold approximately $360, $162, and $17 million dollars of Tempus stock, respectively. Pathos, a Lefkofsky-related company, raised $427 million in two rounds...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0a07ed0-cbbd-44ae-820f-abfd93140362",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "title",
      "text": "Strategic Collaborations: Headline Value, Little Substance, And Related-Party Concerns (Cont'd)",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aebd87ab-720e-48ce-bba7-d7498c637867",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.31,
        "y": 0.05
      },
      "kind": "title",
      "text": "Tempus Has 50% - 60% Downside Risk",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a1c3ba4-f9c3-4e8f-979d-38a70f4258d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "cb17936a-85ec-4f3a-8326-2fdc97b30f98",
      "evidence": "The slide systematically breaks down three separate business relationships to argue they are fraudulent or misleading.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 7,
      "beatId": "019de87d-e3e6-7128-92e2-f4d5dfbf8757",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": null,
      "evidence": "Strong Sell opinion + 50-60% downside thesis pillars stated upfront.",
      "position": 3,
      "confidence": 78,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 11,
      "from": 1,
      "beatId": "019de87d-e4d0-77bf-9508-61d07c6b0663",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Setup & Stakes",
      "beatSlug": null,
      "evidence": "Strong Sell thesis with 50-60% downside stake established.",
      "position": 1,
      "confidence": 55,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}